These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19571557)

  • 21. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of non-surgical periodontal treatment on visfatin concentrations in serum and gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus.
    Wu Y; Chen L; Wei B; Luo K; Yan F
    J Periodontol; 2015 Jun; 86(6):795-800. PubMed ID: 25786566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM.
    Mohammadi S; Hosseinzadeh-Attar MJ; Hosseinnezhad A; Hosseini SH; Eshraghian MR; Nezhad MK; Rahmani M; Karimi M
    Diabetes Metab Syndr; 2011; 5(2):71-5. PubMed ID: 22813406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
    Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
    Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
    Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
    Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ
    J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders.
    Kamińska A; Kopczyńska E; Bieliński M; Borkowska A; Junik R
    Endokrynol Pol; 2015; 66(2):108-13. PubMed ID: 25931039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis.
    Niepolski L; Grzegorzewska AE; Młot-Michalska M
    Int Urol Nephrol; 2010 Jun; 42(2):441-52. PubMed ID: 19184512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].
    de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R;
    Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Visfatin level after laparoscopic Roux-en-Y gastric bypass surgery in patients with Type 2 diabetes].
    Liu Y; Xiong J; He H; Zhu S; Mo Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):258-61. PubMed ID: 23545832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis.
    Esteghamati A; Morteza A; Zandieh A; Jafari S; Rezaee M; Nakhjavani M; Jamali A; Esteghamati AR; Khalilzadeh O
    J Cardiovasc Transl Res; 2012 Aug; 5(4):541-6. PubMed ID: 22585407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome.
    Kocełak P; Olszanecka-Glinianowicz M; Owczarek AJ; Krupa W; Obirek P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Skalska A; Więcek A; Chudek J
    Pol Arch Med Wewn; 2015; 125(6):402-13. PubMed ID: 25924024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum visfatin levels, adiposity and glucose metabolism in obese adolescents.
    Taşkesen D; Kirel B; Us T
    J Clin Res Pediatr Endocrinol; 2012 Jun; 4(2):76-81. PubMed ID: 22672864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes.
    Haider DG; Pleiner J; Francesconi M; Wiesinger GF; Müller M; Wolzt M
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4702-4. PubMed ID: 16895956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
    Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
    Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation Between Circulating Visfatin and Nitric Oxide Metabolites Levels in Patients With Diabetic Nephropathy.
    Akbarian N; Zarghami N; Mota A; Abediazar S; Abroon S; Mihanfar A; Amanzadeh M; Darbin A; Bannazadeh Baghi H; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 May; 12(3):163-168. PubMed ID: 29891746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.